Hensley Mark Earl sold HRTX

August 6, 2026 · Form 4 insider transaction

Hensley Mark Earl sold 8,888 shares of Heron Therapeutics, Inc. at $0.50 per share, a transaction worth $4.4K. The trade was recorded as shares withheld for taxes and disclosed on an SEC Form 4, filed 4 days after the transaction.